🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users administering products of uncertain source.

Some experts said the demand for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Elimination

Based on the social media company, the platform has removed problematic content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also found communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.

After moments of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these groups, messages display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has already encountered individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially significant medical dangers”.